A Phase I/Ii Trial Of Pazopanib Alternating With Bevacizumab In Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma (Ccrcc) Patients: Phase I Results.
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2019)